← Browse by Condition
Medical Condition
chronic hepatitis d infection
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 3
NCT07200908 Phase 3
Recruiting
A Trial Evaluating Brelovitug (BJT-778) vs Bulevirtide for the Treatment of Chronic Hepatitis Delta Infection (AZURE-2)
Enrollment
172 pts
Location
Austria, Czechia, Fr...
Sponsor
Mirum Pharmaceuticals, Inc.
NCT07298330 Phase 3
Recruiting
A Trial Evaluating Brelovitug vs Delayed Treatment for the Treatment of Chronic Hepatitis Delta Infection (AZURE-4)
Enrollment
80 pts
Location
United States, Belgi...
Sponsor
Mirum Pharmaceuticals, Inc.